Subscribe
Subscribe
南微医学
内窥镜下微创诊疗器械研发商
南微医学是一家成立于2000年5月，总部位于中国南京市的内窥镜下微创诊疗器械研发商，创始人为隆晓辉；2019年7月22日，南微医学在上交所上市；主要股东为南京新微创企业管理咨询有限公司、深圳市中科招商创业投资有限公司、Huakang Limited；在中国和全球范围内，和南微医学在业务上有不同程度竞争关系的公司包括天松医疗、爱科凯能、Gordian Surgical、COOP GROUP等。
内窥镜下微创诊疗器械研发商
南微医学是一家成立于2000年5月，总部位于中国南京市的内窥镜下微创诊疗器械研发商，创始人为隆晓辉；2019年7月22日，南微医学在上交所上市；主要股东为南京新微创企业管理咨询有限公司、深圳市中科招商创业投资有限公司、Huakang Limited；在中国和全球范围内，和南微医学在业务上有不同程度竞争关系的公司包括天松医疗、爱科凯能、Gordian Surgical、COOP GROUP等。
With a tenfold increase in net profit in three years, what did Micro-Tech do right?
Micro-Tech (688029.SH): the performance is in line with expectations and the core products continue to expand.
Micro-Tech (688029.SH): brief annual performance exceeded expectations, and the impact of the COVID-19 is gradually recovering.
Strengthen the efforts to develop the market, Mirco-Tech made a profit of CNY 303 million in the past 19 years.
Is there an alternative plan for Micro-Tech, which lost the first instance of the German Patent lawsuit?
Guolian Securities: endoscopic market potential Micro-Tech may benefit
Science and Technology Innovation Board pricing. Micro-Tech: price-to-earnings ratio 36.29 times more than raising 855 million
The proportion of IPO: research and development of the Micro-Tech is on the low side. Their reply is 455 pages.
The overseas market is a drag, Micro-Tech's sales expenses rised rapidly
EqualOcean is an international information service provider and investment research firm that aims to become a global platform for industrial innovation.
We strive to make technology inclusive, accessible and transparent.
Join over 70,000 of your peers
Beijing
9 Xiaguangli, 10F Block A CEC Development Mansion, Chaoyang Dc, Beijing 100125, China
Shanghai
A002, 5F, Ai Tower, 701 Yunjin Road, Xuhui Dc, Shanghai 200232, China
New York
800 Third Ave, 28F, New York, NY 10022, USA
Cooperation strategy
Products & prices
Customers & evaluation
